Search

Displaying results 9351 - 9360 of 10000 in total
  1. Drug

    AZD-3839

    go.drugbank.com/drugs/DB12368
    Investigational

    AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.

  2. Drug

    Tecemotide

    go.drugbank.com/drugs/DB12568
    Investigational

    Tecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell Lung.

    Categories: Complex Mixtures
  3. Drug

    AZD-3043

    go.drugbank.com/drugs/DB12576
    Investigational

    AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.

  4. Drug

    JNJ-41443532

    go.drugbank.com/drugs/DB12632
    Investigational

    JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type 2.

  5. Drug

    Samalizumab

    go.drugbank.com/drugs/DB12636
    Investigational

    Samalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.

  6. Drug

    Nelivaptan

    go.drugbank.com/drugs/DB12643
    Investigational

    Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.

  7. Drug

    GS-9256

    go.drugbank.com/drugs/DB12876
    Investigational

    GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

  8. Drug

    Odalasvir

    go.drugbank.com/drugs/DB13041
    Investigational

    Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.

  9. Drug

    QL1706

    go.drugbank.com/drugs/DB17562
    Investigational

    QL1706 is an investigational bifunctional antibody that combines the activity of both PD-1 and CTLA-4 antibodies.

  10. Drug

    PHE885

    go.drugbank.com/drugs/DB18123
    Investigational

    PHE885 is an investigational, autologous B-cell Maturation Antigen (BCMA)-directed chimeric antigen receptor (CAR)-T cell therapy.